Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory

Relevance. Vaccines are regarded as an effective means for control of the Covid-19 pandemic spreading and their search, analysis, and comparison of their features are important for elucidating the most safe and effective one. Aim. At the end of 2020 two types of vaccines (viral based vaccines and mR...

Full description

Bibliographic Details
Main Author: E. P. Kharchenko
Format: Article
Language:Russian
Published: Numikom LLC 2021-03-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/1174
_version_ 1797879541494972416
author E. P. Kharchenko
author_facet E. P. Kharchenko
author_sort E. P. Kharchenko
collection DOAJ
description Relevance. Vaccines are regarded as an effective means for control of the Covid-19 pandemic spreading and their search, analysis, and comparison of their features are important for elucidating the most safe and effective one. Aim. At the end of 2020 two types of vaccines (viral based vaccines and mRNA vaccines) have been licensed to vaccinate. The aim is to compare their features for objective substantiation of their application. Conclusions. As both vaccine types have high effectiveness in inducing antibodies to SARS-Cov-2 (in more 90% recipients) the utility of each vaccine type in blocking the Covid-19 pandemic spreading is beyond doubt. In both vaccine types eventually S protein is the antigen source, and they have limitations for vaccination. In comparison with the vector vaccines mRNA vaccines may induce serious complications, have the least potential to induce trained immunity and can be included into the recipient’s genome. The low frequency of influenza cases in the current epidemic season serves as an of interference between SARS-Cov-2 and influenza viruses. In epidemic seasons after the Covid-19 pandemic coronaviruses may dominate amongst viruses inducing acute respiratory viruses diseases. It is likely that the decline of the Covid-19 case count (in December-January) in Russia is determined by the heterologous collective immunity formed earlier.
first_indexed 2024-04-10T02:50:17Z
format Article
id doaj.art-b5367bc7e51e4902b2a38f1aad7949aa
institution Directory Open Access Journal
issn 2073-3046
2619-0494
language Russian
last_indexed 2024-04-10T02:50:17Z
publishDate 2021-03-01
publisher Numikom LLC
record_format Article
series Эпидемиология и вакцинопрофилактика
spelling doaj.art-b5367bc7e51e4902b2a38f1aad7949aa2023-03-13T07:43:18ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942021-03-0120141910.31631/2073-3046-2021-20-1-4-19711Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral RespiratoryE. P. Kharchenko0ФГБУН «Институт эволюционной физиологиии и биохимии им. И. М. Сеченова» РАНRelevance. Vaccines are regarded as an effective means for control of the Covid-19 pandemic spreading and their search, analysis, and comparison of their features are important for elucidating the most safe and effective one. Aim. At the end of 2020 two types of vaccines (viral based vaccines and mRNA vaccines) have been licensed to vaccinate. The aim is to compare their features for objective substantiation of their application. Conclusions. As both vaccine types have high effectiveness in inducing antibodies to SARS-Cov-2 (in more 90% recipients) the utility of each vaccine type in blocking the Covid-19 pandemic spreading is beyond doubt. In both vaccine types eventually S protein is the antigen source, and they have limitations for vaccination. In comparison with the vector vaccines mRNA vaccines may induce serious complications, have the least potential to induce trained immunity and can be included into the recipient’s genome. The low frequency of influenza cases in the current epidemic season serves as an of interference between SARS-Cov-2 and influenza viruses. In epidemic seasons after the Covid-19 pandemic coronaviruses may dominate amongst viruses inducing acute respiratory viruses diseases. It is likely that the decline of the Covid-19 case count (in December-January) in Russia is determined by the heterologous collective immunity formed earlier.https://www.epidemvac.ru/jour/article/view/1174covid-19коронавирусвакциныиммунитеторв
spellingShingle E. P. Kharchenko
Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory
Эпидемиология и вакцинопрофилактика
covid-19
коронавирус
вакцины
иммунитет
орв
title Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory
title_full Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory
title_fullStr Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory
title_full_unstemmed Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory
title_short Vaccines against Covid-19: Comparison, Limitations, the Decrease of Pandemic and the Perspective of Viral Respiratory
title_sort vaccines against covid 19 comparison limitations the decrease of pandemic and the perspective of viral respiratory
topic covid-19
коронавирус
вакцины
иммунитет
орв
url https://www.epidemvac.ru/jour/article/view/1174
work_keys_str_mv AT epkharchenko vaccinesagainstcovid19comparisonlimitationsthedecreaseofpandemicandtheperspectiveofviralrespiratory